ANGLE's lead product is the Parsortix cell separation device, which can capture very rare circulating tumour cells in cancer patient blood – even when there is less than one CTC in one billion healthy cells ANGLE also owns a successful specialist technology consultancy and a major investment in a business with a unique computer graphics technology platform ANGLE is a commercially driven specialist medical diagnostic company with pioneering products in cancer diagnostics and foetal health ANGLE was founded by Andrew Newland in 1994 to bridge a gap between research and the market